Short Description Cyclarity Therapeutics develops atherosclerotic crosslink breakers to address aging and extend healthy lifespan.
Description Cyclarity Therapeutics is a leading biotechnology innovator in the longevity ecosystem, focused on atherosclerotic crosslink breakers as a core strategy for combating age-related decline. The company leverages advances in metabolic & pharmacological longevity and partners with premier research institutions to transform scientific discoveries into real-world interventions. With a mission to add healthy years to life, Cyclarity Therapeutics aims to bring evidence‑based solutions from bench to patients and consumers worldwide.
Address 1700 Montgomery St, Suite 240, San Francisco, CA, USA